George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
The azn decision was important here .Shame they didn't release that as separate rns..it certainly warranted it . Its great news. All looks set fair. Commercial revenue for next year not great but I presume expected.
Well done davey on bgne. Id love to see HCM ditch their uk listing and list in Hong Kong .They'd attract a far higher rating . https://www.reuters.com/article/us-hkex-regulation/hkex-to-offer-concessions-for-u-s-and-uk-listed-firms-to-list-in-hong-kong-idUSKCN1G70VE?utm_campaign=trueAnthem:+Trending+Content&utm_content=5a8fd81504d3011f4c63cb08&utm_medium=trueAnthem&utm_source=twitter
No, Its 3000 shares. Will be adding at least another 7000 this month. My timing on buys has been pretty poor on HCM but as I said to Matt when I bought, its a long term investment rather just the hoped for Nasdaq ipo uplift(a big failure admittedly for me) and so far its working out fine . Matt's timing has been pretty good in that respect. Today's news shows Lilly are pretty much on board . They are probably quite happy to pay a bit extra as long as the milestones are passes so I'm ok with them delaying taking up their rights. No big announcements to transform earnings as CH alluded to when you spoke to him. Hopefully we might get something more concrete with resulsts. I really want to hear the AZN savolitiinib decision. That's the biggie for me . Frustrating that they have not gone for phase 3 yet with Tagrisso and Iressa .